Takaaki Takuma

Toyooka Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Takaaki Takuma is a dedicated urologic oncologist whose research centers on the surgical management and novel therapeutic strategies for aggressive bladder cancers. His most impactful work, a 2023 case study documenting a remarkable response to the immunotherapy Avelumab in a patient with the rare and notoriously treatment-resistant plasmacytoid variant of urothelial carcinoma, has garnered 5 citations. This contribution is particularly significant as it offers a potential lifeline for patients with this aggressive histology, where standard chemotherapy often fails. Dr. Takuma’s expertise extends to advanced surgical techniques, including robot-assisted radical cystectomy, as demonstrated in his detailed case report. By bridging the gap between complex surgical intervention and emerging immunotherapeutic options, his work provides critical insights for clinicians managing high-risk bladder cancer. His focused case study serves as a valuable reference point for researchers exploring targeted treatments for rare urologic malignancies, highlighting the importance of personalized medicine in improving outcomes for patients with limited therapeutic options.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
A case of Avelumab response to multiple bone and lymph node metastases of plasmacytoid variant bladder cancer
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Toyooka Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago